ANIXA BIOSCIENCES, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
ANIXA BIOSCIENCES, INC. (ANIX) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 11.77 million shares for the 6-month period ending 2013-04-30, per its 10-Q/A filed 2013-06-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2013-06-19
- ANIXA BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-01-31 was 19.92M shares.
- ANIXA BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2012-01-31 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month |
|---|---|---|
| 2013-04-30 | 11.77M shares 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | 19.92M shares 10-Q/A · filed 2013-03-25 | |
| 2012-04-30 | 0.00 shares 10-Q/A · filed 2013-06-19 | |
| 2012-01-31 | 0.00 shares 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |